KIR2DL5 mutation and loss underlies sporadic dermal neurofibroma pathogenesis and growth

Authors

Corina Anastasaki, Washington University School of Medicine in St. Louis
Sonika Dahiya, Washington University School of Medicine in St. Louis
David H. Gutmann, Washington University School of Medicine in St. Louis

Journal

Oncotarget

Publication Date

2017

Volume

8

Issue

29

Inclusive Pages

47574-47585

Document Type

Open Access Publication

DOI

10.18632/oncotarget.17736

Rights and Permissions

Anastasaki, C., Dahiya, S., & Gutmann, D. H. (2017). KIR2DL5 mutation and loss underlies sporadic dermal neurofibroma pathogenesis and growth. Oncotarget, 8(29), 47574-47585. doi:10.18632/oncotarget.17736. Copyright: Anastasaki et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License 3.0 (CC BY 3.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.

Recommended Citation

Anastasaki, Corina; Dahiya, Sonika; and Gutmann, David H., "KIR2DL5 mutation and loss underlies sporadic dermal neurofibroma pathogenesis and growth." Oncotarget. 8, 29. 47574-47585. (2017).
https://digitalcommons.wustl.edu/open_access_pubs/6050